FAQ Directory

Here are some of the most frequently asked questions about NCQA’s various programs. If you don’t see what you are looking for in one of the entries below, you can  ask a question through My NCQA.

Filter Results
  • Save
  • Email
  • Print

5.29.2018 QI 15 May a practice with one clinician provide the same evidence for both clinicians and staff in QI 15?

Yes. Because the practice has only one clinician, practice-level data would be the same as clinician-level data, and therefore count for both.

This applies to the following Programs and Years:
PCMH 2017

5.29.2018 QI 15 & QI 16 Is it acceptable to demonstrate only how reports from QI 01 are shared with staff, the public and patients?

No. Practices must provide an example of having shared at least one report from each of the following criterion in Competency A: QI 01, QI 02, and QI 04

This applies to the following Programs and Years:

5.29.2018 QI 08 May “improve performance” be a stated performance goal?

No. The performance goal must be quantified (e.g., a number or percentage signifying a specific performance level).

This applies to the following Programs and Years:
PCMH 2017

5.24.2018 KM 14 Can the same report be used if the practice does medication reconciliation at least annually? How is KM 14 different from KM 15?

Yes. Medication reconciliation (KM 14) includes the process to check for drug and condition interactions in addition to confirming the list of medications with the patient (KM 15). The evaluator may probe for the practice’s process to confirm the same report can be used.

This applies to the following Programs and Years:
PCMH 2017

5.24.2018 KM 16 May practices provide new prescription information only for medications relevant to a specific disease of interest?

No. The requirement to provide new information applies to all new medications prescribed to a patient, especially for patients identified in Concept CM as needing care management. Patients may have multiple comorbidities and medications, so it is crucial that they receive information about all medications prescribed to them

This applies to the following Programs and Years:
PCMH 2017

5.24.2018 KM 01 What kind of report is NCQA looking for as evidence, and what is the required reporting period

Practices should provide a report that demonstrates they update patient problem lists based on visits, transfer of information from other providers or information from the patient. As patient problem lists are expected to be updated at least annually, practices will want to monitor their rate on a periodic basis. Practices define the reporting period and frequency that allows meaningful evaluation of data.

This applies to the following Programs and Years:
PCMH 2017

5.24.2018 KM 02 Are practices required to capture information on the entire patient population for the comprehensive health assessment?

Yes. A comprehensive health assessment should be conducted for all patients and described in a documented process so the practice has relevant and documented information about patients' physical health and social and behavioral influences. That information is then utilized to provide appropriate services, interventions and resources to the patient population.

This applies to the following Programs and Years:
PCMH 2017

5.24.2018 KM 16 Do excerpts from medical records indicating that new medications and side effects were reviewed with the patient/family/caregiver meet the requirement?

No. For KM 16, the practice must both (1) generate a report that demonstrates more than 50 percent of patients have documentation in their medical record that they were assessed and provided education on new prescriptions and (2) demonstrate evidence of the process, which could include showing a patient medical record during virtual review. It is up to the practice to determine the best method for sharing new medication information with patients, and the practice should consider patient language, literacy and health literacy in providing information or materials.

This applies to the following Programs and Years:
PCMH 2017

5.24.2018 KM 12 A May practices use HbA1c measurement for KM 12 A?

No. KM 12 A focuses on preventive care services. HbA1c measurement is appropriate for patients with diabetes and meets criteria for KM 12 C (chronic care services).

This applies to the following Programs and Years:
PCMH 2017

5.24.2018 KM 20 What types of evidence are acceptable as examples of demonstrating implementation of clinical decision support?

Use of flow sheets, demonstration of EHR prompts or other evidence of guideline implementation with which the provider is alerted when a specific service or action is needed at the point of care, based on evidence-based guidelines, would meet the intent of KM 20. In addition to the evidence, practices must also provide information on the condition addressed by the clinical decision support and the source of the evidence-based guideline on which the clinical decision support is based. 

Flow charts, copies of guidelines or empty templates do not demonstrate implementation of clinical decision support. These items show the guideline, but do not demonstrate its use at the point of care

This applies to the following Programs and Years:
PCMH 2017

5.24.2018 KM 10 How can we best collect language needs information from all patients in our large population?

Practices could use a variety of methods to collect language needs information on a large patient population. They may collect data from all patients and their families to create a report showing language needs or obtain data from an external source (e.g., data about the local community or its patient population). 

Patients who do not speak English and patients from racial/ethnic minority groups may be less inclined to provide this information. Care should be taken to request the information using methods that respect multi-cultural differences. 

Resource: NCQA’s 2010 Multicultural Health Care Standards (Abbreviated) E-Pub: http://store.ncqa.org/index.php/2010-mhc-standards-and-guidelines-electronic-pub.html  

This applies to the following Programs and Years:
PCMH 2017

5.24.2018 KM 16 Isn’t supplying information on all new prescriptions redundant since the same information is provided by a pharmacy?

No. Although it may be duplicate information, practices cannot assume that the pharmacy provided the information to the patient. Communication and partnership with patients are critical functions of the patient-centered medical home, and practices must ensure that patients/families/caregivers understand why medication was prescribed and its benefits and potential harms to the patient. Additionally, patients might not review prescription information provided by a pharmacy, and information might not be tailored to the needs of the patient/family/caregiver.

This applies to the following Programs and Years:
PCMH 2017